Needle-free flu vaccine delivered via dental floss proves effective in mouse study
In a groundbreaking study published in Nature Biomedical Engineering, scientists have demonstrated a novel, needle-free way to administer flu vaccines — using dental floss. The new method, tested on mice, has shown remarkable success in generating robust immune protection against lethal influenza infection.
A new frontier in vaccine delivery: gumline immunization
The research centers on a unique delivery route through the junctional epithelium — the thin, porous tissue at the base of the gum pocket where gums attach to teeth. This area is highly permeable, making it an ideal site for mucosal vaccine delivery.
Researchers developed gold nanoparticle-coated dental floss carrying various vaccine components, including:
- Inactivated influenza virus
- Immunogenic peptides
- Proteins
- Messenger RNA (mRNA)
The floss was used to “vaccinate” mice by gently flossing their gumlines every two weeks over a 28-day period.
You may like: Regular dental flossing may reduce risk of stroke and irregular heartbeats, study finds
Mice survived lethal flu exposure
Out of 50 mice tested, those that received three doses of the floss-based flu vaccine showed 100% survival after being exposed to a lethal strain of the virus. In contrast, all unvaccinated mice died.
“Floss-based immunization induced strong and sustained immune activation across multiple organs, robust systemic and mucosal antibody responses, and durable protection against lethal influenza infection — independent of age, food and liquid consumption,” the researchers reported.
Inspiration from gum disease research
The study was led by Dr. Harvinder Gill, a bioengineer and now professor at North Carolina State University, who conceived the idea while reading about periodontal disease. He discovered that gum pockets are especially permeable and thought this property could be used for vaccine delivery.
“These findings establish floss-based vaccination as a simple, needle-free strategy that enhances vaccine delivery and immune activation compared with existing mucosal immunization methods,” the authors concluded.
Why this matters
This research could open the door to a new generation of pain-free vaccines, particularly for needle-phobic patients, children, or populations with limited access to traditional healthcare facilities. While the technology is still in the experimental phase, it represents a major innovation in non-invasive immunization techniques.
Stay informed. Stay ahead.
CLICK HERE TO FOLLOW Dental News Pakistan WhatsApp Channel for trusted healthcare updates, expert insights, clinical research, policy news, and dental breakthroughs—delivered directly to you.